MIRA INFORM REPORT

 

 

Report Date :

23.02.2013

 

IDENTIFICATION DETAILS

 

Name :

GEA PHARMA SYSTEMS (INDIA) PRIVATE LIMITED (w.e.f. 07.07.2009)

 

 

Formerly Known As :

ACO-ENGINEERING (INDIA) PRIVATE LIMITED

 

 

Registered Office :

Block No.8, Phase B, Village Dumad, Savil Road, Vadodara – 391 740, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

12.04.2007

 

 

Com. Reg. No.:

04-050513

 

 

Capital Investment / Paid-up Capital :

Rs.47.079 Millions

 

 

CIN No.:

[Company Identification No.]

U29249GJ2007FTC050513

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDA02606C

 

 

PAN No.:

[Permanent Account No.]

AAGCA2753F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of Pharma Industrial Equipments.

 

 

No. of Employees :

300 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 700000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Listing :

--

 

 

Banker’s Note :

--

 

 

Comments :

Subject is an established company having moderate track record. The company is continuously incurring losses from its operations. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country’s growth, which has averaged more than 7% per year since 1997. India’s diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India’s output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis – in large part because of strong domestic demand – and growth exceeded 8% year-on-year in real terms. However, India’s economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government’s fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India’s medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Darshana

Designation :

Account Executive

Contact No.:

91-265-3074215

Date :

21.02.2013

 

 

LOCATIONS

 

Registered Office / Factory :

Block No.8, Phase B, Village Dumad, Savil Road, Vadodara – 391 740, Gujarat, India

Tel. No.:

91-265-3074272/ 3074202/ 3074203 / 3074206

Fax No.:

91-265-3074255

E-Mail :

pharma-india@geagroup.com

ninad.raje@geagroup.com

Website :

http://www.gea-pharma.in

Location :

Owned

 

 

DIRECTORS

 

AS ON 25.09.2012

 

Name :

Mr. Kashyap Upadhyay

Designation :

Director

Address :

H-57, Adarsh Duplex, ITI Crossing, Gorwa, Vadodara – 390 016, Gujarat, India

Date of Birth/Age :

20.06.1966

Date of Appointment :

20.09.2007

DIN No.:

01472012

 

 

Name :

Mr. Raman Manmohan Madhok

Designation :

Director

Address :

1-D, Villa Alto – Monte, Main Street, Nagali Hills Colony, Donapaula, Goa – 403 004, India

Date of Birth/Age :

02.02.1945

Date of Appointment :

28.12.2009

DIN No.:

01798377

 

 

Name :

Mr. Ronald Anthony Youngs

Designation :

Director

Address :

Scarlet Oakes, Ridgway, Pyrford, Working, UK

Date of Birth/Age :

08.02.1952

Date of Appointment :

28.12.2009

DIN No.:

02886912

 

 

Name :

Mr. Anthony Edgar Butler

Designation :

Director

Address :

19, Ridgeway Road, Sahibury, UK

Date of Birth/Age :

08.05.1953

Date of Appointment :

28.12.2009

DIN No.:

02886882

 

 

KEY EXECUTIVES

 

Name :

Ms. Darshana

Designation :

Account Executive

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 25.09.2012

 

Names of Shareholders

No. of Shares

Ninad Sharad Raje

1

GEA Process Engineering (India) Private Limited, India

4707944

TOTAL

4707945

 

AS ON 25.09.2012

 

Equity Shares Break Up

Percentage of Holding

Bodies corporate

100.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Pharma Industrial Equipments.

 

 

Exports :

 

Countries :

  • UK
  • Denmark

 

 

Terms :

 

Selling :

L/C, Cash, Credit (30 Days)

 

 

Purchasing :

Cash, Credit (30 Days)

 

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Installed Capacity

The information pertaining to Installed Capacity is not relevant as the items produced by the Company are of a highly dissimilar nature.

 

Particulars

Production

 

Bulk Milk Cooler (BMC)

5

Fluid Bed Dryer (FBD)

380

Pharma Connect (PMA)

160

Vibro Fluidizer (VF)

0

Ducting

31

Material Handling

33

Others

94

 

703

 

 

GENERAL INFORMATION

 

Customers :

  • Wholesalers
  • Retailers

 

 

No. of Employees :

300 (Approximately)

 

 

Bankers :

  • Royal Bank of Scotland N.V, 7 Alkapuri, R C Dutt Road, Baroda-390007, Gujarat, India

Tel No.:- 91-265-2355900 / 2356000

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Short Term Borrowings

 

 

From Banks

 

 

Loans Repayable on demand

67.275

57.600

Other Loans and Advances (Specify Nature)

(3.434)

33.540

 

 

 

TOTAL

63.841

91.140

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Keyur Patel and Company

Chartered Accountant

Address :

SF - 14, Hiravanti Chambers, Opposite Aaryakanya Vidhyalaya, Karelibaug, Vadodara-390018, Gujarat, India

Tel. No.:

 

Mobile No.:

 

Fax No.:

 

E-Mail :

 

PAN No.:

AKVPP0199E

 

 

Holding Company :

GEA Process Engineering (India) Private Limited

CIN No:- U74999MH1992PTC065230

 

 

Associates :

v  GEA Courtoy NV

v  GEA Ecoflex India Private Limited

v  GEA Niro-GEA Process Engg A/S

v  GEA Pharma Systems Limited

v  GEA Pharma Systems NV

v  GEA Process Engg (NPS) Limited

v  GEA Tuchenhagen GmbH

v  WestfaliaSurge Deutschland GmbH

v  WestfaliaSurge Japy SAS

v  GEA Pharma Systems AG

v  GEA IT-Services GmbH

v  GEA Process Engineering Pte Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

5110000

Equity Shares

Rs.10/- each

Rs. 51.100 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

4707945

Equity Shares

Rs.10/- each

Rs. 47.079 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

47.079

47.079

47.079

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

130.413

145.600

232.268

4] (Accumulated Losses)

0.000

0.000

(36.334)

NETWORTH

177.492

192.679

243.013

LOAN FUNDS

 

 

 

1] Secured Loans

63.841

91.140

0.000

2] Unsecured Loans

183.499

43.999

88.447

TOTAL BORROWING

247.340

135.139

88.447

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

424.832

327.818

331.460

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

308.711

305.578

265.471

Capital work-in-progress

0.957

0.446

21.946

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

7.811

14.650

14.651

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

127.609
95.370
63.075

 

Sundry Debtors

135.801
53.568
31.211

 

Cash & Bank Balances

12.814
8.793
16.040

 

Other Current Assets

104.134
60.240
0.000

 

Loans & Advances

24.156
18.460
20.270

Total Current Assets

404.514

236.431

130.596

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

150.545

95.899

53.501

 

Other Current Liabilities

118.147
115.325
34.593

 

Provisions

28.469
18.063
13.377

Total Current Liabilities

297.161

229.287

101.471

Net Current Assets

107.353
7.144
29.125

 

 

 
 

MISCELLANEOUS EXPENSES

0.000

0.000

0.267

 

 

 

 

TOTAL

424.832

327.818

331.460

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

418.728

266.755

60.688

 

 

Other Income

13.776

4.934

1.383

 

 

TOTAL                                     (A)

432.504

271.689

62.071

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Increase /Decrease is Inventories

NA

28.206

(24.380)

 

 

Cost of Material and Other Manufacturing Expenses

 

143.056

44.635

 

 

Employee Cost

 

52.716

21.933

 

 

Administrative Expenses

 

66.006

15.814

 

 

Selling and Distribution Expenses

 

6.210

0.292

 

 

Preliminary Expenses Written Off

 

0.134

0.134

 

 

TOTAL                                     (B)

NA

296.328

58.428

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

NA

(24.639)

3.643

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

NA

12.647

6.891

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

5.969

(37.286)

(3.248)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

NA

13.048

0.279

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                (G)

NA

(50.334)

(3.527)

 

 

 

 

 

Less

TAX                                                                  (H)

NA

0.000

(0.205)

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

(15.187)

(50.334)

(3.322)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

NA

(36.334)

(33.012)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

NA

(86.668)

(36.334)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Sales

179.599

96.404

46.809

 

 

Sales Commission

0.597

4.250

1.140

 

 

Income from Dire Services

7.749

1.829

0.000

 

TOTAL EARNINGS

187.945

102.483

47.949

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

79.200

65.578

10.145

 

 

Capital Goods

2.237

3.343

0.103

 

TOTAL IMPORTS

81.437

68.921

10.248

 

 

 

 

 

 

Earnings Per Share (Rs.)

(3.23)

(10.69)

(7.69)

 

 

Expected Sales (2012-2013) : Rs. 750.000 Millions

 

The above information has been parted by Ms. Darshana.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

(3.51)
(18.53)
(5.35)

 

 

 
 
 

Net Profit Margin

(PBT/Sales)

(%)

NA
(18.87)
(5.81)

 

 

 
 
 

Return on Total Assets

(PBT/Total Assets}

(%)

NA
(9.04)
(0.89)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

(0.26)

(0.01)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.39

0.70

0.36

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.36

1.03

1.29

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOAN

 

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Short Term Borrowings

 

 

Loans and advances from related parties

183.499

43.999

 

 

 

TOTAL

183.499

43.999

 

 

SUNDRY CREDITORS DETAILS

(Rs. In Millions)

Particulars

 

31.03.2012

31.03.2011

31.03.2010

Sundry Creditors

 

 

 

- Micro Enterprises and Small Enterprises

0.000

0.000

0.000

- Others

150.545

95.899

53.501

 

 

 

 

TOTAL

150.545

95.899

53.501

 

 

NOTE

 

Registered office of the company has been shifted from Block No.8, Village Dumad, Savali Road, Vadodara – 391 740, Gujarat, India to the present address w.e.f. 22.07.2009.

 

 

OUTLOOK

 

ECONOMY

 

During the year 2011-12 there was slowdown in growth of Indian Economy as it grew by 6.9% [Estimated] in 2011-12 mainly due to weakening industrial growth which retreated significantly by 37.5%. For the current financial year, they expect Indian Economy to grow by less than 6%.

 

The fiscal 2011.12 was also marked by a sharp depreciation of the Indian rupee. On month-to-month basis the rupee depreciated by 12.4 per cent from 44.97 per US dollar in March 2011 to 51.34 per US dollar in January 2012. Rupee reached a peak of 43.94 on 27 July 2011 and lowest at 54.23 per US dollar on 15 December 2011 indicating a depreciation of 19 per cent. The Reserve Bank of India was required to sell dollar5 twice in the fiscal to help raise the value of the rupee. The pressure on Indian rupee is expected to continue.

 

Trade deficit widened from expected USD 160 billion to USD 180 billion for April-March 2011-12, a rise of 52% on a year on year basis. Rising cast of oil imports due to oil prices being higher by aver 7% on a year on year basis pushed up overall imports by 28.5% while export growth was muted at 17.5% leading to a surge in trade deficit.

 

The slowing global economy and the resulting nervous sentiment on the financial markets could lead to lower consumer spending and capital expenditure projects being postponed in many cases. The company has envisaged these events and is planning to

 

  • Cater its products to industries like Dairy and Chemical maintaining its focus on Pharma industry.

 

  • Foray into 5E Asian and markets

 

 

PHARMACEUTICALS

 

According to McKinsey, the Indian Pharma Industry will grow to USD 55 Billion by 2020 with a potential to reach US0 70 Billion in an aggressive growth scenario. Over 2009, the industry is expected to grow with a CARG at 17% till 2020. A growth of 16.5% in 2011-12 is indicative of the built up expectations.

 

A large number of patent expirations continue to offer strong growth prospects for generic players in the developed markets. While patent expires are expected to peak out in 2012, they believe that the growth momentum would sustain as most of Indian companies have a fairly well spread out product pipeline till 2014. They have therefore seen many large size Indian companies and MNC's undertaking expansion for building production of drugs expiring patent. A shift to SEZ's by these companies is seen since most of the large scale players in the industry are either suppliers to Multi Nationals overseas or are themselves planning a foray in developed markets. This is adding advantage to your company which is 100% Export Oriented Unit.

 

 

OPERATIONS

 

The gross sales and other income for the financial year were Rs. 432.500 Millions as against Rs. 275.510 Millions for the previous financial year registering an increase of 1.57 times. The profit before depreciation and tax stood at Rs. 5.970 Millions against loss of Rs. 50.200 Millions recorded in previous year. The net loss stood at Rs. 15.190 Millions (Rs. 50.330 Millions previous year).

 

 

FIXED ASSETS

 

  • Factory Building
  • Plant and Machinery
  • Air Conditioners
  • Computer and Peripherals
  • Electrical Fittings
  • Furniture and Fixture
  • Office Equipments
  • Other Equipments
  • Software and Licenses

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 54.42

UK Pound

1

Rs. 83.20

Euro

1

Rs. 71.90

 

 

INFORMATION DETAILS

 

Information Gathered by :

JML

 

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

5

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.